Bin Wang

机构：Tianjin Normal University, Shanxi University, Capital Medical University, Guangdong Pharmaceutical University, Longgang Central Hospital, Beijing Chest Hospital, National Institutes for Food and Drug Control · ORCID：0000-0003-1577-567X

发表论文 115 篇 · 总被引 2478 次 · h-index 27

代表论文

• Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease (2025 · Journal of Medicinal Chemistry · 被引 16)
• Probing Protein Structural Changes in Alzheimer’s Disease via Quantitative Cross-linking Mass Spectrometry (2024 · Analytical Chemistry · 被引 12)
• Nuclear receptor Rev‐erbα alleviates intervertebral disc degeneration by recruiting NCoR – HDAC3 co‐repressor and inhibiting NLRP3 inflammasome (2024 · Cell Proliferation · 被引 9)
• Comparison of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT for diagnosis and staging of gastric and colorectal cancer (2024 · Nuclear Medicine Communications · 被引 9)
• Mass Spectrometry-Based Precise Identification of Citrullinated Histones via Limited Digestion and Biotin Derivative Tag Enrichment (2024 · Analytical Chemistry · 被引 6)
• CDC25A inhibition suppresses cell proliferation and induces G 1 /S‑phase cell cycle arrest in nasopharyngeal carcinoma (2023 · Molecular Medicine Reports · 被引 6)